최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.33 no.2, 2023년, pp.122 - 127
장민교 (경북대학교 약학대학, 약학연구소) , 이영화 (경북대학교 약학대학, 약학연구소) , 정현숙 (경북대학교 약학대학, 약학연구소) , 신광희 (경북대학교 약학대학, 약학연구소)
Background: This study was aimed to identify the safety signals of metoclopramide in Korea Adverse Event Reporting System (KAERS) database by proportionality analysis methods. Methods: The study was conducted using Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting Syst...
Albibi R, McCallum RW. Metoclopramide: Pharmacology and?Clinical application. Ann Intern Med 1983;98(1):86-95.
Junqueira DR, Bennett D, Huh SY, Fahrbach K, Neupane B, Betts?M. Risk of Adverse Events Associated with Domperidone and?Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis. Drugs R D 2023;23(1):1-20.
European Medicines Agency. European Medicines Agency?recommends changes to the use of metoclopramide. Available from:?https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-changes-use-metoclopramide. Accessed March 7, 2023.
The Ministry of Food and Drug Administration. Pharmaceutical?integrated information system. Available from: https://nedrug.mfds.go.kr/searchDrug. Accessed April 22, 2023.
Drugwatch. Reglan & Tardive Dyskinesia. Available from: https://www.drugwatch.com/reglan/. Accessed June 22, 2023.
U.S Food and Drug Administration. FDA online label repository.?Available from: https://labels.fda.gov/. Accessed March 8, 2023.
Micromedex. Micromedex system database. Available from: https://www.micromedexsolutions.com/home/dispatch. Accessed March 8, 2023.
Baek J-W, Yang BR, Choi S, Shin K-H. Signal Detection for?Adverse Events of Finasteride Using Korea Adverse Event?Reporting System (KAERS) Database. KJCP 2021;31(4):324-31.
Jang M-G, Gu H-J, Kim J, Shin K-H. Signal detection for adverse?event of varenicline in Korea Adverse Event Reporting System.?KJCP 2022;32(1):1-7.
Miller LG, Jankovic J. Metoclopramide-induced movement?disorders. Clinical findings with a review of the literature. Arch?Intern Med 1989;149(11):2486-92.
Yis U, Ozdemir D, Duman M, Unal N. Metoclopramide induced?dystonia in children: two case reports. Eur J Emerg Med 2005;12(3):117-9.
Moos DD, Hansen DJ. Metoclopramide and extrapyramidal?symptoms: a case report. J Perianesth Nurs 2008;23(5):292-9.
Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in?an infant. Mov Disord 2005;20(1):86-9.
Lang L. FDA Calls for Boxed Warning for Metoclopramide.?Gastroenterology 2009;136:2039.
Ehrenpreis ED, Deepak P, Sifuentes H, Devi R, Du H, Leikin JB.?The Metoclopramide Black Box Warning for Tardive Dyskinesia:?Effect on Clinical Practice, Adverse Event Reporting, and?Prescription Drug Lawsuits. Am J Gastroenterol 2013;108(6):866-72.
Surawski RJ, Quinn DK. Metoclopramide and Homicidal Ideation:?A Case Report and Literature Review. Psychosomatics 2011;52(5):403-9.
Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic?neuropathy. Nat Rev Dis Primers 2019;5(1):42.
Kim H, Suh HS. Effects of a Safety Letter on Metoclopramide Use?in Korea: An Interrupted Time-Series Analysis. Risk Manag Healthc?Policy 2020;13:1335-41.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.